J. Fruchart, Analyse moléculaire des lipoprotéines athérogènes et protectrices : Applications cliniques ? Le Biologiste, 1987.

J. L. Duff, Mc Millian G.C.-Pathology of atherosclerosis ?, Am.J.Med, pp.11-92, 1951.

, World Health Organization-Classification atherosclerotic lesions. W.H.O. technical report series N° 143, 1958.

P. Ducimetiere, J. L. Richard, J. R. Claude, and J. Warner, Les cardiopathies ischémiques : incidences et facteurs de risque. ln : L'étude prospective parisienne, p.lnserm, 1981.

G. Sezille, J. C. Fruchart, and J. Jaillard, Lipides et lipoprotéines ? Métabolisme et méthodes d'exploration : applications au diagnostic et à la physiopathologie des hyperlipidémies ? Crouan et Roques Eds

J. Fruchart, Lipides ou lipoprotéines: quels paramètres choisir pour évaluer le risque cardiovasculaire? Feuillets de biologie, vol.1, p.39, 1987.

W. B. Kannel, W. P. Castelli, T. Gordon, and P. Mc-namara, Serum cholesterol , lipoproteins and the risk of coronary heart disease, Ann. lntem. Med, pp.74-75, 1971.

G. Sezille, J. C. Fruchart, and J. Jaillard,

B. Zak, Cholesterol methodologies : a review, Clin. Chem. {, pp.23-1201, 1977.

M. L. Girard and F. Rousselet, Problèmes de biochimie appliquée: 8ème série lipides , lipoprotéines et athérosclérose-Masson Ed. ( 197 6) Paris. ( 11) d'après Fruchart J.C.-Exploration biochimique classique des lipides et des lipoprotéines, Crouan et Roques Eds, issue.6

S. A. Cobbs and J. L. Sander, Enzymatic determination of cholesterol in serum lipoproteins separated by electrophoresis, Rev. Med. lnt, vol.83, issue.13, p.1266, 1978.

H. Parra, C. Fievet, B. Boniface, J. C. Fruchart, P. Boulanger et al., Eds Raven Press ( 1984) 187 , 197. ( 16) Conseil d'administration d' ARCOL-Consensus français sur le cholestérol et les dyslipoprotéinémies, Exposés annuels de biochimie médicale 31 èmes séries, vol.11, 1972.

D. Seidel, Human plasma lipoproteins : biochemical and clinical aspects, Ann. Clin. Biochem, vol.283, pp.19-278, 1982.
DOI : 10.1177/000456328201900417

URL : http://journals.sagepub.com/doi/pdf/10.1177/000456328201900417

J. L. Schlienger, F. Grunenberger, and . Lp, ) Beucler 1.-Métabolisme des lipoprotéines ? XXXI 1 èmes dimanches biologiques ( 1992) 17 , 27 ? (23) Alaupovic P.-The role of apolipoproteins in lipid transport processes, 21) d'après Assmann G.-Lipid metabolism and atherosclerosis, vol.840, pp.12-15, 1921.

G. Schonfeld and B. Pfleger, The stucture of human high density lipoprotein and the levels of apolipoprotein A 1 in plasma as determined by radioimmunoassay, Dyslipidémies : étude biologique , clinique et thérapeutique. Gazette médicale, vol.91, pp.10-89, 1984.

P. N. Durrington, J. T. Whicher, and C. Warren, A comparison of methods for the electrophoresis assay of serum apolipoprotein in man, Clin. Chem, issue.6, pp.71-95

S. Moulin, P. Dewailly, G. Sezille, and J. Fruchart, Electrophorèse des lipoprotéines sur plaque de gel d'acrylamide en gradient discontinu d'acrylamide, Clin Chim. Acta, pp.91-159, 1979.
DOI : 10.1016/0009-8981(79)90451-0

J. C. Fruchart, Puchois P.-Méthodes d'analyse des lipoprotéines, Ann. Biol. Clin, vol.555, pp.44-551, 1986.

J. C. Osborne and H. B. Brewer, The plasma lipoproteins ?, Adv.protein Chem, pp.31-253, 1977.

J. J. Albers, Multilaboratory comparison of three heparin Mn 2+ precipitation procedures for estimating cholesterol in high density lipoprotein, Clin. Chem, pp.24-853, 1978.

G. R. Warnick and J. J. Albers, Heparin Mn 2 + quantitation of high density lipoprotein cholesterol. An ultrafiltration procedure for lipemic samples, Clin. Chem, pp.24-900, 1978.

O. F. Delalla, J. W. Gofman, T. Gordon, W. P. Castelli, M. C. Hjortland et al., High density lipoprotein as a protective factor against coronary heart disease ? The Framingham study. Amer, Methods Biochem Anal, pp.62-707, 1977.

N. E. Miller and D. S. Thelle, Forde 0.H.-High density lipoprotein and coronar heart disease : a prospective case control study. The Lancet ( 1977). (35) d'après Rhoads G.G. , Gulbransen C.L., kagan A.-Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men, New Engl. J. Med, vol.294, p.293, 1976.

?. F. Riese, R. Mordasini, and C. Salzmann, Apoproteins and lipids as dicriminators of severity of coronary heart disease, Atherosclerosis, vol.162, pp.37-157, 1980.

J. J. Albers, V. G. Cabana, and G. R. Warnick, Lp (a) lipoprotein : relationship to sinking pre-beta lipoprotein , hyperlipoproteinemia and apolipoprotein B. Metabolism ( 1975) 24-1047. (38) d'après Desreumaux C. , Fruchart J.C., Dewailly P.-Purification et caractérisation partielle de la lipoprotéine Lp (a), Biochimie, pp.59-543, 1977.

D. Seidel, A new immunochemical technique for a rapid semi-quantitative determination of the abnormal lipoprotein (Lp X) caracterizing cholestatis, Clin. Chim. Acta, pp.31-225, 1971.

S. Ritland, Quantitativedetermination of the abnormal lipoprotein of cholestatis, Lp X in liver disease, Scand. J. Gastroenterol, p.48, 1975.

H. B. Brewer, J. T. Fairwell, and L. Kay, Human sequence pro-Apo A 1 : isolation and aminoterminal sequence, Biochem. Biophys. Res. Commun, pp.113-115, 1983.

J. C. Fruchart, . Luyeye-1, and H. Parra, Les lipoprotéines athérogènes et leur détection immunologique ? Bull. Acad, pp.111-115, 1985.

P. Kwiterovitch and A. Sniderman, Clinical and biochemical caracteristics of dyslipoproteinemias associated with an excess of apoprotein B or A 1 : proceeding of the workshop on apolipoprotein quantification ? N.l.H. publication N° 83 {1983, vol.100, pp.1266-71

G. Utermann, M. Hees, and A. Steinmetz, Polymorphism of apolipoprotein E and occurence of dysbetalipoproteinemia in man ?, Nature, p.607, 1977.

A. L. Catapano, Apo C Il and lipoprotein lipase activity .Rie, Clin. Lab, vol.40, pp.12-35, 1982.

H. Tolleshang, J. L. Goldstein, and W. Sneider, Post-translational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia, Cell, vol.44, issue.5, pp.30-715, 1982.

U. Beisiegel, W. J. Schneider, M. S. Brown, and J. L. Goldstein, lmmunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia, J. Biol. Chem, pp.257-13150, 1982.

H. Tolleshang, K. K. Hobgood, and J. L. Goldstein, The LDL receptor locus in familial hypercholesterolemia : multiple mutations disrupt transport and processing of a membrane receptor, Cell, pp.32-941, 1983.

J. D. Brunznell, A. Chait, E. A. Nikkila, and G. Ehnholm, Heterogeneity of primary lipoprotein lipase deficiency, pp.29-624, 1980.

E. A. Nikkila, Familial lipoprotein lipase deficiency and related disorders of chylomicron metabolism .ln : The metabolic basis of inherited disease 5 th Eds, p.642, 1982.

S. C. Rall, K. H. Weisgraver, and R. W. Malhey, Structural basis for receptor binding heterogeneity of apolipoprotein E from type 111 hyperlipoproteinemic subjects, Proc. Natl.Acad. Sei, pp.79-4696, 1982.

S. M. Grundy, ) d'après Legrand A.-Les méthodes d'exploration des lipoprotéines et les problèmes rencontrés dans leur utilisation, J. Lipid Res, issue.56, pp.25-1611, 1984.

G. Siest, _Henn:yJ.,.5chiele f. _-_Références en biologie clinique

. Paris, , 1990.

. Beucler-1, E. Caces, and R. Camare, 59) d'après Fievet C. , Desreumaux C.-Lipides, lipoprotéines , apoprotéines : évolution des méthodes d'exploration depuis 10 ans, Ann. Biol. Clin, vol.447, p.341, 1990.

K. Berg, C DNA sequence of human apolipoprotein (a) is homologous to plasminogen ?, A new serum type system in man : the Lp system ? Acta Pathol. Microbiol. Scand, vol.382, pp.330-132, 1987.

G. Koster, San Diego ( 1990) 183, 204. (63) d'après, The physiological role of Lp(a)

, Ann. Biol. Clin, p.153, 1990.

J. J. Albers, S. Marcovina, and M. Lodge, 65) d'après Legrand A.-Lipides et lipoprotéines : éléments de l'exploration et leurs limites, Références médicales : le texte des douze premières ? Impact Medecin Quotidien { 1993) N° 459, vol.58, pp.177-53, 1990.